Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network
Titel:
Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network
Auteur:
Amoroso, Loredana Castel, Victoria Bisogno, Gianni Casanova, Michela Marquez-Vega, Catalina Chisholm, Julia C. Doz, François Moreno, Lucas Ruggiero, Antonio Gerber, Nicolas U. Fagioli, Franca Hingorani, Pooja Melcón, Soledad G. Slepetis, Ruta Chen, Nianhang le Bruchec, Yvan Simcock, Mathew Vassal, Gilles